Former Novartis exec to lead Cambridge diabetes startup Semma
May 10, 2018 at 07:00 AM EDT
Bastiano Sanna previously oversaw the development of Novartis' CAR-T drugs, a new class of medicines that are designed to reprogram a person’s cells to fight cancer.
